Trade Allogene Therapeutics, Inc. - ALLO CFD

Trading Conditions

• Type: CFD
• Spread: 0.03
• Long position overnight funding adjustment: -0.02151%
• Short position overnight funding adjustment: -0.00071%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 10
• Margin: 50.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 2.2
• Open: 2.37
• 1-Year Change: 52.9%
• Day's Range: 2.33 - 2.47

Trade Allogene Therapeutics, Inc. - ALLO CFD

What is Allogene Therapeutics, Inc. (ALLO)?

Allogene Therapeutics, Inc. is a biotechnology company focused on the development of allogeneic chimeric antigen receptor T-cell (CAR T) therapies for cancer treatment. The company specializes in creating off-the-shelf CAR T cell products derived from healthy donors, aiming to provide scalable and accessible immunotherapies. Its research and development efforts target hematologic malignancies and solid tumors, leveraging gene editing technologies to enhance the safety and efficacy of its therapies. Allogene Therapeutics collaborates with academic institutions and industry partners to advance its pipeline and expand its scientific capabilities. The company operates within the broader field of cellular immunotherapy, contributing to innovations in cancer treatment by addressing limitations associated with autologous CAR T therapies, such as manufacturing complexity and treatment delays. Headquartered in the United States, Allogene Therapeutics is part of the biotechnology sector and engages in clinical development activities to bring novel therapies from laboratory research to patient care.

Allogene Therapeutics, Inc. Stock Price Today: Live Overview

The price today is shaped by active trades, with Elevance Health Inc. showing a price of $2.45. During the session, it has moved between $2.22 and $2.48 with a daily percentage change of +9.5023%.

FAQ: Allogene Therapeutics, Inc. (ALLO)

What is the current price of ALLO stock?

The latest price is $2.45.

Does ALLO pay dividends?

Dividends are not paid by the company.

Does ALLO have a formal corporate presence or regional headquarters in the UAE?

Allogene Therapeutics, Inc. operates through partners and distributors in the UAE without a direct regional presence.

What is ALLO best known for?

Allogene Therapeutics, Inc. is most famous for its work in allogeneic CAR T-cell therapy development.

What assets are typically shown together with ALLO?

Commonly shown alongside ALLO: Greenidge Generation Holdings Inc., Etoro Group ltd, Fast Retailing Co., Ltd.